cover image: Chronic Wounds Treatment With Active Halogen Agents

20.500.12592/5j51qj

Chronic Wounds Treatment With Active Halogen Agents

Comming across to chronic wounds in clinical practice, I have encountered how devastating is the clinical unresolved cases of chronic wounds. Many patients with e.g. reduced immune system as in nephropathy and elder, suffer from chronic wounds that in many cases may become life threatening. In modern medicine newer compounds are required to become employed in clinical practice to offer increase antimicrobial activity and act through redox therapy to close wounds. What is it about?Novel Treatment Of Chronic wounds With Active Halogen Compounds And Active Amines. To efficiently cure chronic wounds resistant to all other known agents as antibiotics, steroid compounds and known disinfectants. The use of taurine derivative compounds will help to solve many unsolved clinical cases of chronic wound persisting even for many years. Thsi will elevate both quality and quantity of human life. Why is it important?Chronic wounds, are a major medical unsolved problem nowadays. The impact of driving to wound closure with new active agents as taurine derivatives : N Chlorotaurine and N-Bromotaurine as well as new active amines as Bromamine T will be highly significant. Multibacterial chronic skin infections as well as biofilm skin diseases will benefit enormously with new treatment regimes.

Authors

Anthony Kyriakopoulos

Institution
Nasco AD Biotechnology Laboratory Pireus Greece
Number of Briefings
1
Number of Outputs
3
Published in
United Kingdom